Brief: Microbot Medical Announces $5 Mln Registered Direct Offering
21/10/2022 13:04
Oct 21 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL ANNOUNCES $5 MILLION REGISTERED DIRECT
OFFERING
PRICED AT-THE-MARKET UNDER NASDAQ RULES
* MICROBOT MEDICAL - INTENDS TO USE PROCEEDS FOR CONTINUED
DEVELOPMENT, COMMERCIALIZATION AND REGULATORY ACTIVITIES FOR
LIBERTY ROBOTIC SYSTEM
* MICROBOT MEDICAL INC - CLOSING OF REGISTERED DIRECT
OFFERING AND
CONCURRENT PRIVATE PLACEMENT IS EXPECTED TO OCCUR ON OR ABOUT
OCTOBER 25, 2022
* MICROBOT MEDICAL - ANNOUNCED IT HAS ENTERED INTO
DEFINITIVE
AGREEMENT WITH SINGLE INSTITUTIONAL INVESTOR FOR SALE AT
PURCHASE PRICE OF $4.89 PER SHARE
Source text for Eikon: ID:nGNX8Br0vy
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones